Explore evidence

10 per_100000The annual rate of cervical cancer deaths per 100,000 females in Senegal was 10.0 for the 35–39 years age group, according to GLOBOCAN 2022.

Sénégalcancer du col de l'utérusobserved 2022HAL · Unilimdocument of 111 observations

3.4 %L’enquête STEPS7 de l’ANSD réalisée en 2015 au Sénégal a montré une prévalence du diabète de 3,4 %.

Sénégaldiabète (non précisé)observed 2015HAL · Unilimdocument of 857 observations

47 yearsThe median age of patients with homozygous sickle cell disease in this cohort was 47 years.

Sénégaldrépanocytosepublished 2024Advances in hematologyeurope_pmcdocument of 9 observationsDOI 10.1155/2024/7501577

Reticulocyte-derived microparticles were significantly negatively associated with a history of priapism (P = 0·020).

Sénégaldrépanocytose · priapismpublished 2021British journal of haematologyeurope_pmcdocument of 5 observationsDOI 10.1111/bjh.17242

50 %The frequency of the TLR2 rs4696480 TA genotype was 50% in the bacterial infection group and 67% in the non-infection group.

Sénégalbacterial infectionpublished 2019British journal of haematologyeurope_pmcdocument of 4 observationsDOI 10.1111/bjh.15875

5.2 %La prévalence du VIH chez les consommateurs de drogues injectables était de 5,2 % au Sénégal, contre 0,5 % en population générale.

SénégalVIH/sidaHAL · Unilimdocument of 92 observations

80 %80 % des drépanocytaires évoquent la fatigabilité comme un problème impactant leur scolarisation.

SénégaldrépanocytoseHAL · Unilimdocument of 857 observations

47 %47 % des élèves drépanocytaires considèrent leur parcours scolaire comme bon.

SénégaldrépanocytoseHAL · Unilimdocument of 857 observations

115.8 per_100000The annual rate of cervical cancer deaths per 100,000 females in Senegal was 115.8 for the 70–74 years age group, according to GLOBOCAN 2022.

Sénégalcancer du col de l'utérusobserved 2022HAL · Unilimdocument of 111 observations

1.75 IRRMalaria risk was highest during week 4 after SMC round 4, with an incidence rate ratio (IRR) of 1.75.

SénégalpaludismeHAL · Unilimdocument of 60 observations

10 %Only 10% of Senegalese women have ever been screened for cervical cancer.

Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations

100 %A 100% increase in malaria risk occurred from day 28 to day 34 after SMC treatment uptake.

SénégalpaludismeHAL · Unilimdocument of 60 observations

8 %La résidence en milieu rural était associée à une légère augmentation de la prévalence de l'anémie, d'environ 8 %, chez les drépanocytaires au Sénégal.

SénégalanémieHAL · Unilimdocument of 857 observations

38.41 %The readmission rate for sickle cell emergencies was 38.41%.

Sénégaldrépanocytosepublished 2024Anemiaeurope_pmcdocument of 5 observations

7 strategiesSeven HPV vaccination strategies were identified along the cost-effectiveness frontier.

Sénégalinfection à HPVHAL · Unilimdocument of 111 observations

7.6 %HIV-1 serology test was positive in 7.6% of patients with microscopy-positive pulmonary tuberculosis.

Sénégaltuberculoseobserved 2015-2016published 2018The Pan African medical journalPubMeddocument of 13 observations

En 2011, les femmes CDI incluses dans l'étude UDSEN avaient des taux de prévalence du VHC et du VIH plus élevés que les hommes.

SénégalVHC · VIH/sidaobserved 2011HAL · Unilimdocument of 92 observations

527 per_1000_person_yearsL'incidence du paludisme était de 527 cas par 1000 personnes-années chez les enfants âgés de 10 à 14 ans.

SénégalpaludismeHAL · Unilimdocument of 117 observations

0.3 %Plasmodium falciparum malaria prevalence was 0.3% in Keur Soce, central Senegal, among children under 10 years old.

Sénégalpaludismeobserved 2010published 2015Malaria journalPubMeddocument of 8 observations

La prévalence de Plasmodium falciparum persiste pendant la saison sèche à faible prévalence chez tous les groupes d’âge âgés de 10 ans et plus.

Sénégalpaludismeobserved saison sècheHAL · Unilimdocument of 117 observations

61.9 %In a cohort of 295 sickle cell disease children from the Dakar pediatric hospital in Senegal, 61.9% of β S /β S patients were homozygous for the XmnI polymorphism.

Sénégaldrépanocytosepublished 2017Hemoglobineurope_pmcdocument of 6 observations

15 %Highly effective treatment of haemophilia A and B is primarily available to 15% of the world's population, in high-income countries.

Sénégalhaemophilia A and Bpublished 2022The Lancet. Haematologyeurope_pmcdocument of 4 observations

95.1 %In this cohort study, 95.1% of patients with homozygous sickle cell disease had less than 3 vaso-occlusive crises per year.

Sénégaldrépanocytosepublished 2024Advances in hematologyeurope_pmcdocument of 9 observationsDOI 10.1155/2024/7501577

56 %Parmi les participants de l’étude (n = 100), 56 % étaient homozygotes pour la drépanocytose (HbSS).

SénégaldrépanocytoseHAL · Unilimdocument of 30 observations

11,000,000,000 clotting_factor_unitsThe 2022 World Federation of Haemophilia Annual Global Survey revealed that 11 billion clotting factor units are available to treat haemophilia A and B globally.

Sénégalhaemophilia B · Hemophilia Aobserved 2022published 2024Haemophilia : the official journal of the World Federation of Hemophiliaeurope_pmcdocument of 4 observations